Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Everest Group Positions Broadridge in the Highest Leader Position in Market Impact and as a Star Performer in Wealth Management Products PEAK Matrix® Assessment 2024
-
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
-
SurplusGLOBAL to Participate in SEMICON JAPAN 2024, Showcasing AI-Based 'SemiMarket' and Legacy Equipment Solutions
-
ST Engineering iDirect Releases Industry-first Breakthrough Multi-Orbit Capability
-
Cellenkos Presents Phase 1b Data at ASH 2024 Showcasing the Potential of T-Regulatory Cell Therapy Candidate CK0804 for Myelofibrosis
-
Will You Accept This Castle for Christmas? Gifting Trends on Dating.com
-
PricingDirect and Aumni Partner to Deliver Independent Valuations for Private Equity Securities
-
PENTAX Medical obtained US FDA 510(k) clearance for new models of the PENTAX Medical i20c Video Endoscope Series
-
Vince Holding Corp. Reports Third Quarter 2024 Results
-
ICE Launches Long European Union Bond Index Futures
-
USU Positioned as the Leader in the 2024 SPARK Matrix™ for Software Asset Management (SAM) Tools by QKS Group
-
Beneficient Hires Industry Veteran Louise Jones to Lead Capital Markets and Custody Business Line Operations
-
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
-
CorriXR Therapeutics Names Eric Kmiec Chief Executive Officer
-
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions
-
GlobalMeet Unveils New Live Studio Control Room for Enhanced Virtual Event Production
-
Syntara announces positive interim data in Phase 2 study of SNT-5505 in myelofibrosis
-
Park Place Plans Expansion On Newly Acquired Land In Texas
-
ProPetro Announces ProPWRSM Power Generation Business
-
THE POINTS GUY UNVEILS WINNERS OF THE SEVENTH-ANNUAL TPG AWARDS
-
IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Mee
-
Porter Airlines Lands in Thunder Bay with First Embraer E195-E2 Connecting Toronto-Pearson
-
CES Power Acquires Base Craft, a Provider of Specialty Services and Equipment for the Motion Picture Industry
-
TruArc Partners Invests in DMI Personal Care
-
RealSelf’s Inaugural Real Talk Report Uncovers That Despite a GLP-1 Boom, Consumers Invested in Body Contouring Treatments in 2024
-
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
-
CONMED Corporation Announces Quarterly Cash Dividend
-
Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development
-
Bask Health: Pioneering Telehealth and Transforming Access to GLP-1 Medications in a Booming Industry
-
HRCI Announces Board Expansion; Welcomes Two New Directors
-
Yelp Unveils a Series of New AI-powered Features to Enhance Discovery and Connection with Local Businesses
-
Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts
-
Auguria Debuts Enhanced Security Knowledge Layer Platform at Black Hat Europe
-
NewBiologix Launches U.S. Subsidiary and Welcomes Gene and Cell Therapy Expert David Kelly as Business Development Manager
-
Bybit Web3 Boosts its Supports to L1 Ecosystems at Taipei Blockchain Week 2024 with Co-hosted Solana and Sui Events
-
Indian Hill Exempted Village School District Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students
-
StorPool Achieves 85% 5-Star Gartner Peer Insights Rating in 2024
-
CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies
-
HASI Prices Reopening of $300 Million of 6.375% Green Senior Unsecured Notes due 2034
-
MoneyHero Group Reports Third Quarter 2024 Results
-
Microbix Assisting EMQN with Novel Genetic-Test EQA Program
-
Mobilicom Secures Production Orders From U.S. Customer for Use in High Payload Long Range Drones
-
Better Choice Company Increases Capital Stock Distribution of Halo as Part of the SRx Health Transaction from an 8% to 17% Dividend
-
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Fami
-
G-III Apparel Group, Ltd. Reports Third Quarter Fiscal 2025 Results Above Guidance; Updates Fiscal 2025 Outlook
-
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium
-
NORDICUS now trading under symbol NORD
-
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
-
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
-
United Natural Foods, Inc. Reports First Quarter Fiscal 2025 Results

